Fine tuning an old-school chemotherapy drug
Monday, May 5, 2014 - 05:10
in Health & Medicine
First approved by the FDA in the 1970s, the chemotherapy drug cisplatin and its relative carboplatin remain mainstays of treatment for lung, head and neck, testicular and ovarian cancer. However, cisplatin's use is limited by its toxicity to the kidneys, ears and sensory nerves.